跳至主要内容
临床试验/ISRCTN90916365
ISRCTN90916365已完成未知

The clinical and cost effectiveness of lamotrigine for people with borderline personality disorder: a randomised controlled trial

Imperial College London (UK)0 个研究点目标入组 276 人开始时间: 2012年8月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
276

研究概览

简要总结

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Age 18 and above
  • 2. Fulfilling Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) diagnostic criteria for borderline personality disorder
  • 3. Competent and willing to provide written, informed consent

排除标准

  • 1. Currently fulfilling criteria for bipolar affective disorder (type I & II), or psychotic disorder (schizophrenia, schizoaffective disorder, or mood disorder with psychotic features)
  • 2. Already being prescribed a mood stabiliser(s)
  • 3. Daily use of alcohol or illicit drugs during the previous three months
  • 4. Known medical history of liver or kidney impairment
  • 5. Cognitive or language difficulties that would preclude subjects providing informed consent or compromise participation in study procedures
  • 6. Any woman who is pregnant or planning a pregnancy, and any woman of child bearing potential unless using adequate contraception

研究者

发起方
Imperial College London (UK)

相似试验